Pamela Wapnick's most recent trade in Metagenomi Inc. was a trade of 144,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 24,000 | 211,375 | - | 0 | Common Stock | |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 05 Mar 2026 | 1,581 | 187,375 | - | 1.6 | 2,530 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 05 Dec 2025 | 1,576 | 188,956 | - | 1.8 | 2,793 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.60 per share. | 05 Sep 2025 | 120,000 | 190,532 | - | 1.6 | 192,000 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 05 Sep 2025 | 1,576 | 70,532 | - | 1.8 | 2,853 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 06 Jun 2025 | 1,576 | 72,108 | - | 1.8 | 2,758 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 84,000 | 84,000 | - | - | Stock Option (Right to Buy) | |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 14,000 | 73,684 | - | 0 | Common Stock | |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 05 Mar 2025 | 1,808 | 59,684 | - | 1.9 | 3,390 | Common Stock |
| Metagenomi Inc | Wapnick Pamela | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 05 Dec 2024 | 1,559 | 61,492 | - | 1.9 | 2,900 | Common Stock |
| Metagenomi Inc | Wapnick Pamela | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.88 per share. | 05 Sep 2024 | 6,265 | 63,051 | - | 2.9 | 18,043 | Common Stock |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 291,450 | 291,450 | - | - | Stock Option (Right to Buy) | |
| Metagenomi Inc | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 69,316 | 69,316 | - | 0 | Common Stock |